Want to see FR:LBIRD full AI Analyst Report?
LBIRD Stock Chart & Stats
€25.15
-€0.05(-0.19%)
At close: 4:00 PM EDT
€25.15
-€0.05(-0.19%)
Day’s Range― - ―
52-Week Range€17.75 - €28.70
Previous CloseN/A
Volume37.74K
Average Volume (3M)22.17K
Market Cap
€595.84M
Enterprise Value€551.13
Total Cash (Recent Filing)€61.60M
Total Debt (Recent Filing)€146.20M
Price to Earnings (P/E)41.9
Beta0.36
Next Earnings
Sep 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.42%
Share Statistics
EPS (TTM)0.62
Shares Outstanding22,466,883
10 Day Avg. Volume19,968
30 Day Avg. Volume22,172
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)2.31
Price to Sales (P/S)2.08
P/FCF Ratio37.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.93
Revenue Forecast (FY)€246.43M
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthRevenue growth of 8.9% and a history of steady expansion support ongoing demand for Lumibird’s laser and imaging offerings. Although recent growth has moderated to low single digits, the multi-year trend still provides a durable base for scale.
Improved ProfitabilityNet margin improved to about 6.2% in 2025 from 2.7% in 2024, while operating margin also increased. This earnings inflection suggests better execution or mix and gives the business more internal capacity to fund development, even though consistency remains unproven.
Manageable LeverageDebt-to-equity ended 2025 at about 0.71, within the pack’s historical 0.54–0.81 range, while equity and assets expanded. This suggests leverage is manageable and supports operating scale, although it is not light enough to remove balance-sheet risk.
Bears Say
Volatile Free Cash FlowOperating cash flow is positive but inconsistent, while free cash flow was materially negative in 2022 and 2023 before recovering. This history indicates working-capital swings and/or meaningful capex needs, which can limit dependable self-funded growth.
Weak Cash Conversion2025 free cash flow was only about 30% of net income. Weak conversion means reported earnings may not translate reliably into deployable cash, reducing flexibility for investment, debt reduction, or shareholder returns over the medium term.
Moderating Growth And Margin VisibilityRevenue growth has slowed to low single digits in 2024–2025 after stronger earlier expansion, while margins have varied across years. The reported zero 2025 gross profit also reduces confidence in the quality and durability of the margin improvement.
LBIRD FAQ
What was Lumibird SA’s price range in the past 12 months?
Lumibird SA lowest stock price was €17.75 and its highest was €28.70 in the past 12 months.
What is Lumibird SA’s market cap?
Lumibird SA’s market cap is €595.84M.
When is Lumibird SA’s upcoming earnings report date?
Lumibird SA’s upcoming earnings report date is Sep 29, 2026 which is in 18 days.
How were Lumibird SA’s earnings last quarter?
Lumibird SA released its earnings results on Mar 17, 2026. The company reported €0.413 earnings per share for the quarter.
Is Lumibird SA overvalued?
According to Wall Street analysts Lumibird SA’s price is currently Overvalued.
Does Lumibird SA pay dividends?
Lumibird SA pays a Notavailable dividend of €0.37 which represents an annual dividend yield of 1.42%. See more information on Lumibird SA dividends here
What is Lumibird SA’s EPS estimate?
Lumibird SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lumibird SA have?
Lumibird SA has 22,466,883 shares outstanding.
What happened to Lumibird SA’s price movement after its last earnings report?
Lumibird SA reported an EPS of €0.413 in its last earnings report. Following the earnings report the stock price went down -4.891%.
Which hedge fund is a major shareholder of Lumibird SA?
Currently, no hedge funds are holding shares in FR:LBIRD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lumibird SA
A global leader, Lumibird S.A. specializes in the development, manufacturing, and distribution of a wide array of laser technologies. Its sophisticated laser products are deployed worldwide across scientific, industrial, and medical sectors. The company's operations are divided into two key segments: Photonics and Medical. Within its Photonics division, Lumibird offers an extensive portfolio, including solid-state lasers, high-power laser diodes, fiber lasers, and related amplifiers and components. This segment also provides advanced photonics solutions for time-of-flight LiDAR, range-finding, and Doppler LiDAR systems for wind measurement. These offerings are critical for industrial and scientific advancements, defense and space operations, and diverse LiDAR sensing needs. Concurrently, the Medical division delivers comprehensive medical and ophthalmological solutions, encompassing everything from diagnosis to laser-based therapies. Established in 1970, Lumibird S.A. maintains its corporate headquarters in Lannion, France.
Technical Analysis
bioMerieux
―
MAUNA KEA TECHNOLOGIES
―
Sartorius Stedim Biotech
―
Theraclion SA
―
Median Technologies
―